To test the physiological impact of activated hepatic acetylcholine-CHRNA2 signaling during metabolic adaptation upon calorie overload, we adopted an early disease stage of the diet-induced MASH model with reversible pathologies. This evidence concerns the gene CHRNA2 and metabolic dysfunction-associated steatohepatitis.